Introduction {#s1}
============

Socioeconomic status (SES), a multi-dimensional construct encompassing economic resources, power and social standing, has been associated with a number of health outcomes.[@pone.0089482-Braveman1]--[@pone.0089482-Luo1] Understanding the mechanisms behind such associations is necessary in order to reduce health disparities. Among adult patients, strong evidence exists supporting socioeconomic gradients in cancer mortality. [@pone.0089482-Woods1].

By contrast, the equivalent pediatric literature is sparse and predominantly restricted to low- and middle-income countries (LMIC). [@pone.0089482-Tang1], [@pone.0089482-Mostert1] High-income country (HIC) studies have yielded seemingly contradictory results.[@pone.0089482-McWhirter1]--[@pone.0089482-Charalampopoulou1] Given differences in cure rates and developmental position, adult socioeconomic gradients cannot be extrapolated to children with cancer.

We therefore undertook the first systematic review of the literature examining the impact of SES upon pediatric oncology outcomes. Our primary objective was to determine the impact of income- and education-based measures of SES on event-free survival (EFS), overall survival (OS) and disease-free survival (DFS) among children with cancer. Secondary objectives included determining the effect of other SES measures, as well as the effect of SES on treatment-related mortality (TRM), relapse and abandonment of therapy.

Methods {#s2}
=======

The conduct of the review followed the PRISMA framework. [@pone.0089482-Moher1] Both the PRISMA Checklist and the initial protocol can be found in [Checklist S1](#pone.0089482.s007){ref-type="supplementary-material"} and [Text S1](#pone.0089482.s004){ref-type="supplementary-material"}.

Data Sources {#s2a}
------------

We performed electronic searches of Ovid Medline, EMBASE and CINAHL from inception to December 10^th^, 2012 with the assistance of a library scientist. The Medline search strategy is illustrated in [Table 1](#pone-0089482-t001){ref-type="table"}, with complete strategies illustrated in [Text S2](#pone.0089482.s005){ref-type="supplementary-material"}.

10.1371/journal.pone.0089482.t001

###### Medline Search Strategy.

![](pone.0089482.t001){#pone-0089482-t001-1}

  Set                                                                                                                                                                     History                                                                                                                                                                      Results            Comments
  ----- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------- --------------------------
  1      "emigration and immigration"/or residence characteristics/or "catchment area (health)"/or housing/or public housing/or health status disparities/or Healthcare Disparities/or ruralhealth services/or suburban health services/or urban health services/or exp Insurance/orexp Health Services Accessibility/or exp Socioeconomic Factors/    54,3627           SES Terms
  2                                                                                                                                                                    Exp Neoplasms/                                                                                                                                                                 2,416,057        Neoplasm terms
  3                                                                                                                                                                       1 and 2                                                                                                                                                                     3,227,924      Base clinical set
  4                                                                                                                                                        limit 3 to "all child (0 to 18 years)"                                                                                                                                                       4,042         Age group limit
  5                                                                                                                              (infan\* or child\* or adolescen\* or youth\* orteen\* or pediatric\* or paediatric\*).mp.                                                                                                                           2,961,284   Age group textword terms
  6                                                                                                                                                                    4 or (3 and 5)                                                                                                                                                                   4,533          FINAL Results

Study Selection {#s2b}
---------------

Inclusion and exclusion criteria were defined *a priori*. Inclusion criteria were: (1) ecologic, cross-sectional, cohort, case-control or randomized control trial designs; (2) pediatric data available, with pediatric ages defined by authors, and (3) at least one pre-specified survival-related outcome reported by subgroups defined by a pre-specified socioeconomic variable (see below). Biologic factors may account for a portion of the disparities in outcome seen between different ethnic groups. [@pone.0089482-Harvey1] Since the independent effects of biology and SES cannot be disentangled when ethnicity is the sole proxy of SES, such studies were excluded. There was no restriction by language. Two reviewers (SG, MW) independently evaluated identified titles and abstracts, retrieved any potentially relevant manuscript and determined eligibility; discrepancies were resolved through consensus. Agreement between reviewers was assessed using the kappa statistic. [@pone.0089482-Landis1] Non-English articles were assessed with the assistance of pediatric oncologists whom were native speakers of the relevant language.

Data Abstraction {#s2c}
----------------

Two reviewers (SG, MW) independently abstracted data using standardized forms. The primary outcomes were EFS, OS and DFS; secondary outcomes were specific causes of treatment failure (TRM, relapse, abandonment). Relative survival was assumed to be comparable to OS. Multiple measures of SES exist in the literature, reflecting three main domains: material resources, knowledge related assets and social standing. [@pone.0089482-Marmot1] Though income and education (including measures of occupation) were the key variables of interest in this study, we included a broad range of SES measures reflecting these domains: material possession (e.g. car ownership), family composition (e.g. marital status), health insurance status, health care accessibility and immigrant status. Both ecologic and individual-level variables were included. When measures over multiple time periods were available, only the most contemporaneous time period was recorded. Study authors were contacted to solicit missing data.

Study quality was assessed using a framework of potential biases developed by Hayden et?al to evaluate prognosis studies. [@pone.0089482-Hayden1] Four key indicators of study quality relevant for studies examining the impact of SES were identified *a priori*: (1) the degree to which study samples reflected underlying populations, (2) whether loss to follow-up was associated with socioeconomic characteristics, (3) whether potential confounders were accounted for and (4) the appropriateness of the analysis. Further details are provided in the online supplemental data. When assessing the degree to which study samples represented the general population, samples derived from clinical trials were judged to be only partly representative of the overall population, as patients of low SES who consent to trials may be systematically different than those who do not. [@pone.0089482-Simon1], [@pone.0089482-Drotar1] Single institution studies were also assessed as only partly representative. The loss to follow-up quality indicator was judged not applicable for settings in which abandonment of therapy constituted a significant cause of treatment failure. [@pone.0089482-Mostert2] As various indicators measure different domains of socioeconomic position, accounting for confounding was assessed as adequate if both a measure of disease risk and a second SES indicator were included. Analyses that were not based on time-to-event data were assessed as partially adequate.

Analysis {#s2d}
--------

Given the anticipated heterogeneity in settings, SES measures and malignancies, no quantitative meta-analyses were planned. The magnitude and underlying mechanisms of any association between SES and outcome are likely to differ between developing and developed countries. The results were therefore summarized separately for LMIC and for HIC, as defined by the World Bank using Gross National Income per capita (LMIC \<\$12,616 vs. HIC ≥\$12,616). [@pone.0089482-TheWorld1].

As the unit of analysis varied markedly even among studies investigating a common SES variable (e.g. per unit of monthly income vs. per income quintile), we could not compare magnitudes of association across studies. Consequently, measures of association between SES and outcome were plotted on a single graph in which sample size was represented on the x-axis. Positive associations (defined as higher SES associated with better outcome) were placed to the right of the y-axis while negative associations (defined as higher SES associated with worse outcome) were placed to the left, regardless of statistical significance or magnitude. Points more distal from the y-axis therefore do not represent greater degrees of association. When the SES measure was categorical (e.g. income quintiles), the direction of the association was determined by comparing outcomes between the highest and lowest SES categories. For each study, associations for only the highest aggregation of cancers were presented. Statistically significant associations were displayed in red and non-significant associations in black.

For studies describing the effect of dichotomous measures of income or insurance upon EFS, OS or DFS in acute lymphoblastic leukemia (ALL) or Hodgkin lymphoma (HL), the proportion of adverse outcomes attributable to low SES (attributable risk) was calculated by the following formula (p~e~ = proportion of the population exposed to the adverse prognosticator; RR = ratio of the cumulative incidence of adverse outcome in the two groups): [@pone.0089482-Rockhill1] ALL and HL were chosen as they account for a significant percentage of incident cases of childhood cancer. The concept of attributable risk assumes that the relationship is causal and that no significant bias or confounding exists. Attributable risks were also calculated for recently discovered biologic prognosticators as comparators. These prognosticators were chosen by the authors based on their prominence in either clinical practice (e.g. minimally residual disease) or laboratory research (e.g. CRLF2 expression).

Ethics Statement {#s2e}
----------------

Institutional review board approval was not required as only group-level, and not individual-level data were obtained from already published studies.

Results {#s3}
=======

[Figure 1](#pone-0089482-g001){ref-type="fig"} illustrates the flow of study identification and selection. A total of 7,737 abstracts were identified by the search strategy; 527 articles in ten languages were retrieved for full evaluation. Of these, 36 met eligibility criteria. The kappa statistic of agreement between the two reviewers was 0.82 (95% confidence interval (CI) 0.72--0.91). Characteristics of the included studies, including indicators of study quality, are shown in [Table 2](#pone-0089482-t002){ref-type="table"}. Though most studies were of acceptable quality, only half accounted for potential confounders.

![PRISMA flow diagram.](pone.0089482.g001){#pone-0089482-g001}

10.1371/journal.pone.0089482.t002

###### Characteristics of included studies.
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  Characteristic                                                                              Studies, N (%)  
  ------------------------------------------------------------------------------------------ ---------------- -----------
  Malignancy                                                                                                  
  All cancers                                                                                    0 (0.0)       8 (30.8)
  Leukemia or lymphoma                                                                           9 (90.0)      15 (57.7)
  Solid tumor                                                                                    1 (10.0)       1 (3.8)
  Central nervous system tumor                                                                   0 (0.0)        2 (7.7)
  Type of socioeconomic variable examined                                                                     
  Ecologic                                                                                       1 (10.0)      13 (50.0)
  Income-based                                                                                   7 (70.0)       2 (7.7)
  Education-based[a](#nt102){ref-type="table-fn"}                                                6 (60.0)      10 (38.5)
  Other[b](#nt103){ref-type="table-fn"}                                                          5 (50.0)      10 (38.5)
  Sample Size                                                                                                 
  \<100                                                                                          1 (10.0)      4 (15.4)
  100**--**999                                                                                   9 (90.0)      9 (34.6)
  1,000**--**9,999                                                                               0 (0.0)       12 (46.2)
  ≥10,000                                                                                        0 (0.0)        1 (3.8)
  Restricted to adolescents/young adults[c](#nt104){ref-type="table-fn"}                                      
  Yes                                                                                            0 (0.0)        2 (7.7)
  No                                                                                            10 (100.0)     24 (92.3)
  Study sample adequately reflective of general population[d](#nt105){ref-type="table-fn"}                    
  Yes                                                                                            8 (80.0)      21 (80.7)
  No/Partial/Unsure                                                                              2 (20.0)      5 (19.2)
  Loss to follow-up unrelated to socioeconomic status[d](#nt105){ref-type="table-fn"}                         
  Yes                                                                                            3 (30.0)      21 (80.7)
  No/Partial/Unsure                                                                              1 (10.0)      5 (19.2)
  Not applicable                                                                                 6 (60.0)       0 (0.0)
  Potential confounders accounted for[d](#nt105){ref-type="table-fn"}                                         
  Yes                                                                                            6 (60.0)      12 (46.2)
  No/Partial/Unsure                                                                              4 (40.0)      14 (53.8)
  Analysis appropriate[d](#nt105){ref-type="table-fn"}                                                        
  Yes                                                                                            8 (80.0)      18 (69.2)
  No/Partial/Unsure                                                                              2 (20.0)      8 (30.8)

HIC -- high-income countries; LMIC -- low- and middle-income countries.

Also included occupation-based measures of socioeconomic status.

Included measures of material possession, family composition, insurance status, immigrant status, and health care accessibility.

As defined by study authors.

See supplemental data for definitions of study quality variables.

Low- and Middle-income Country Studies {#s3a}
--------------------------------------

The results of the ten eligible LMIC studies are shown in [Table 3](#pone-0089482-t003){ref-type="table"}, with full details available in [Table S1](#pone.0089482.s002){ref-type="supplementary-material"}. Of the ten, seven found at least one measure of low SES to be significantly associated with inferior outcome.[@pone.0089482-Bonilla1]--[@pone.0089482-Wang1] The remaining three found no significant association.[@pone.0089482-Gupta1]--[@pone.0089482-Pedrosa1] When restricted to studies examining the primary outcomes of EFS, OS or DFS, 6/7 (85.8%) studies showed at least one statistically significant association where lower SES was associated with worse survival.

10.1371/journal.pone.0089482.t003

###### Eligible studies examining the impact of socioeconomic status upon outcome in children with cancer in low- and middle-income countries.

![](pone.0089482.t003){#pone-0089482-t003-3}

                     Country          Malignancy          N      OutcomeMeasure              Ecologic Measures                                                            Income Measures                                                 Education Measures[a](#nt108){ref-type="table-fn"}                                       Other SES Measures
  --------------- ------------- ---------------------- -------- ---------------- ------------------------------------------ ------------------------------------------------------------------------------------------------------------ ---------------------------------------------------- --------------------------------------------------------------------------------------------
  Bonilla 2010     El Salvador    Standard risk ALL      260          EFS                          **--**                                                       **HR 0.84; Per \$100** **increase**                                            **HR 0.49; ≥Secondary vs.** **≤primary**                                          Telephone ownership NS
  **--**             **--**             **--**          **--**       **--**                        **--**                                                                      **--**                                                                           **--**                                                            Mode of transport NS
  **--**             **--**         High risk ALL        183          EFS                          **--**                                                                 Monthlyincome NS                                                               Parentaleducation NS                                                    Telephone ownership NS
  **--**             **--**             **--**          **--**       **--**                        **--**                                                                      **--**                                                                           **--**                                                            Mode of transport NS
  Mostert 2010      Indonesia            ALL             283          EFS                          **--**                                    **HR 2.6; 2nd/3rd class ward vs.** **VIP/1st class ward, based on income**                                         **.**                                                                    **.**
  Tang 2008           China              ALL             346          EFS                          **--**                                                                      **.**                                                                            **--**                         **5-year EFS 61.2% urban vs. 30.3%** **rural; p\<0.0001** [c](#nt110){ref-type="table-fn"}
  Dinand 2007         India        Hodgkin Lymphoma      145          EFS                          **--**                                  **HR 5.4; Low vs.** **high Kuppuswami score** [b](#nt109){ref-type="table-fn"}                                       **--**                        
  Pedrosa 2007       Brazil      Non-Hodgkin Lymphoma    110           OS                          **--**                                                                 Family income NS                                                              Maternal education NS                                                            **--**
  Carlos 2002        Mexico         Retinoblastoma       552           OS         **HR 2.38; Most marginalized vs. least**                                                     **--**                                                                           **--**                                                                   **--**
  Viana 1998         Brazil              ALL             167          DFS                          **--**                    **5-year DFS 58% for those \>0.4 ×** **minimum wage vs. 8% for those \<0.4 ×** **minimum wage; p\<0.0001**                         **--**                                **\>4 kw hours daily electric consumption vs.** **\<4 kw hours; p = 0.0003**
  **--**             **--**             **--**          **--**       **--**                        **--**                                                                      **--**                                                                           **--**                                         **Very poor vs. fair-good housing conditions; p = 0.006**
  Gupta 2009       El Salvador           AML              78          TRM                          **--**                                                                Monthly income NS                                                              Parental education NS                                                    Telephone ownership NS
  **--**             **--**             **--**          **--**       **--**                        **--**                                                                      **--**                                                                           **--**                                                        Number of family members NS
  **--**             **--**             **--**          **--**       **--**                        **--**                                                                      **--**                                                                           **--**                                                        Cost to travel to clinic NS
  Wang 2011           China              ALL             323      Abandonment                      **--**                                                                      **--**                                                                   Paternal education NS                          **32.5% abandonment good housing conditions** **vs. 83.3% poor; p\<0.001**
  **--**             **--**             **--**          **--**       **--**                        **--**                                                                      **--**                                                                   Maternal education NS                                                            **--**
  Kulkarni 2010       India              ALL             532      Abandonment                      **--**                                               Kuppuswami score NS[b](#nt109){ref-type="table-fn"}                                                     **--**                                                                   **--**

ALL -- acute lymphoblastic leukemia; AML -- acute myeloid leukemia; DFS -- disease free survival; EFS -- event free survival; HR -- hazard ratio; N -- number; NS -- non-significant; OS -- overall survival; SES -- socioeconomic status; TRM -- treatment related mortality.

Bolded variables indicate statistically significant associations. Magnitudes of non-significant associations and confidence intervals of significant associations can be found in [Table S1](#pone.0089482.s002){ref-type="supplementary-material"}, along with definitions of each variable.

Education measures also include occupation-based measures.

Aggregate score based on income, education and occupation.

Urban residents also had medical insurance while rural residents did not.

[Figure 2](#pone-0089482-g002){ref-type="fig"} illustrates each association between a socioeconomic variable and outcome plotted by study sample size, restricted to LMIC studies examining EFS, OS or DFS. One Brazilian study of non-Hodgkin lymphoma provided log rank p values of without information on the directions of association; none of these were statistically significant. [@pone.0089482-Pedrosa1] Regardless of the SES measure chosen, lower SES was always associated with inferior EFS/OS/DFS, with the majority of associations statistically significant. There were no studies that showed that lower SES was associated with better survival irrespective of statistical significance.

![Associations between socioeconomic measures and event-free and overall survival in low- and middle-income countries.\
A. Measures of material possession, family composition, insurance status, immigrant status, and health care accessibility. B. Measures of education and occupation. C. Measures of income. Positive = lower socioeconomic status associated with inferior outcome; Negative = lower socioeconomic status associated with superior outcome. Magnitudes of association are not plotted. Statistically significance is denoted in red. Data points with a number above represent multiple socioeconomic variables.](pone.0089482.g002){#pone-0089482-g002}

High-income Country Studies {#s3b}
---------------------------

The results of the 26 eligible studies conducted in HIC are shown in [Table 4](#pone-0089482-t004){ref-type="table"}, all of which used EFS or OS as their outcome. Full details are available in [Table S2](#pone.0089482.s003){ref-type="supplementary-material"}. Individual-level and ecologic measures of SES were used by 13 (50.0%) and 10 (38.5%) studies respectively; three studies (11.5%) used both. Of the 26, 14 (53.8%) showed at least one measure of low SES to be significantly associated with inferior outcome.[@pone.0089482-Charalampopoulou1], [@pone.0089482-Birch1]--[@pone.0089482-Youlden1].

10.1371/journal.pone.0089482.t004

###### Eligible studies examining the impact of socioeconomic status upon outcome in children with cancer in high-income countries.
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                                                                                             Country            Outcome Measure      Malignancy         N                                  Ecologic Measures                                     Income Measures             Education Measures[a](#nt113){ref-type="table-fn"}                                  Other SES Measures
  --------------------------------------------------------------------------------- -------------------------- ----------------- ------------------- ------- ----------------------------------------------------------------------------- ---------------------------- ------------------------------------------------------------ --------------------------------------------------------------------------
  Metzger 2008                                                                                 USA                    EFS         Hodgkin lymphoma     327                  **HR 1.9; High** **poverty county** **vs. low**                             --                                         **--**                                                                --
  Bhatia 2002                                                                              USA, Canada                EFS                ALL          1596                                        --                                        Annual household income NS                      Paternal educationNS                                                         --
  --                                                                                            --                    --                 --            --                                         --                                                    --                                  Maternal educationNS                                                         --
  Hann 1981                                                                                  England              5 year EFS             ALL           209                                        --                                                    --                                 Paternal occupationNS                                                         --
  Lightfoot 2012                                                                     England, Scotland, Wales         OS                 ALL          1559                    **HR 1.29;** **Deprived vs.** **affluent**                                --                                 Paternal occupationNS                                                         --
  Syse 2012                                                                                   Norway                  OS               Cancers        6280                                        --                                           Household income NS               **OR 1.2; ≤High** **school vs. ≥College**                                       Marital status NS
  --                                                                                            --                    --                 --            --                                         --                                                  **--**                                         --                                                        Number of children NS
  Rondelli 2011                                                                               Italy                   OS                 ALL          3522                                        --                                                  **.**                                          --                                             **HR 1.70; Immigrant** **vs. non-immigrant**
  Walsh 2011[b](#nt114){ref-type="table-fn"}                                                 Ireland               5 year OS         All Cancers      1440                              SAHRUdeprivationindexNS                                         --                                           --                                                                  --
  Youlden 2011                                                                              Australia              5 year OS           Cancers        6289                               Disadvantageindex NS                                           --                                           --                                                **HR 1.55; Remote** **vs. Major city**
  Crouch 2009[c](#nt115){ref-type="table-fn"}                                                   UK                 5 year OS         All cancers       654             **Affluent 70% OS to** **deprived 64%;** **trend p\<0.5**                        --                                           --                                                                  --
  Hsieh 2009                                                                                   USA                    OS                 NB           1777                                      **--**                                                **--**                                       **--**                             **5-year OS Urban** **county 63% OS vs.** **rural county 55%; p = 0.04**
  Kent 2009                                                                                    USA                    OS              Leukemias       4158                          Census-baseddeprivationindex NS                                     --                                           --                                         **HR 1.56; Any** **insurance vs.** **none/unknown**
  Birch 2008[b](#nt114){ref-type="table-fn"} ^,^ [c](#nt115){ref-type="table-fn"}            England               5 year OS         All Cancers      31722              **Affluent 71% to deprived 70%;** **trend p = 0.001**                          --                                           --                                                                  --
  Moschovi 2007                                                                               Greece                  OS                 MB            50                                         --                                                    --                                 Maternal education NS                                               Place of residence NS
  Perez-Martinez 2007[d](#nt116){ref-type="table-fn"}                                         Spain                5 year OS         All cancers       90+                                        --                                                    .                                            --                                                         Immigrant status NS
  Tseng 2006                                                                              England, Wales           5 year OS        Malignant CNS     3169                                 Carstairsindex NS                                            --                                           --                                                                  --
  Charalampopolou 2004                                                                        Greece                  OS                 ALL           293                                        --                                                    --                                  Maternaleducation NS                                         **HR 2.85; Other vs.** **married**
  --                                                                                            --                    --                 --            --                                         --                                                    --                                           --                                                      **HR 0.63;** **Per child**
  Coleman 1999                                                                            England, Wales           5 year OS      Hodgkin lymphoma     189                                 Carstairsindex NS                                            --                                           --                                                                  --
  --                                                                                            --                    --                 NHL           273                                 Carstairsindex NS                                            --                                           --                                                                  --
  --                                                                                            --                    --                 CNS          1050                                 Carstairsindex NS                                            --                                           --                                                                  --
  --                                                                                            --                    --                Wilms          257                                 Carstairsindex NS                                            --                                           --                                                                  --
  --                                                                                            --                    --                 OST           117                                 Carstairsindex NS                                            --                                           --                                                                  --
  --                                                                                            --                    --                 ES            97                                  Carstairsindex NS                                            --                                           --                                                                  --
  --                                                                                            --                    --                 STS           319                                 Carstairsindex NS                                            --                                           --                                                                  --
  --                                                                                            --                    --                 GCT           121                                 Carstairsindex NS                                            --                                           --                                                                  --
  McKinney 1999[e](#nt117){ref-type="table-fn"}                                                 UK                    OS             All Cancers      1979                                 Carstairsindex NS                                            --                                           --                                                                  --
  Schillinger 1999                                                                        England, Wales           5 year OS             ALL          5566                                 Carstairsindex NS                                            --                                           --                                                                  --
  Coebergh 1996                                                                            Netherlands             5 year OS      Standard-risk ALL    367                                        --                                                    --                                  Parentaleducation NS                                                         --
  --                                                                                            --                    --            High-risk ALL      141                                        --                                                    --                                  Parentaleducation NS                                                         --
  --                                                                                            --                    --                 AML           67                                         --                                                    --                                  Parentaleducation NS                                                         --
  Hord 1996                                                                                    USA                 5 year OS             ALL           178                                        --                                                    --                                           --                                **OR 0.61; Total insurance coverage vs. at least partially uncovered**
  Petridou 1994                                                                               Greece                  OS              Leukemias        120                                        --                                                    .                                  Paternaloccupation NS                                         **HR 0.29; Private car vs. none**
  --                                                                                            --                    --                 --            --                                         --                                                    --                                  Paternaleducation NS                                             Maternity hospital type NS
  --                                                                                            --                    --                 --            --                                         --                                                    --                                  Maternaleducation NS                                            Ability to choose doctor NS
  McWhirter 1983                                                                            Australia              5 year OS             ALL           70                                         --                                                    --                      **High social class 59%** **OS vs. low 27%**                                             --
  Szklo 1978                                                                                   USA                 2 year OS             ALL           55     **High rental** **value 51% OS** **vs. low rental** **value 28%; p\<0.005**               --                                           --                                                                  --
  Byrne 2011                                                                                   USA              Medianduration     AML (Age 0--9)      84                              Communitypoverty level NS                                        --                                           --                                                                  --
  --                                                                                            --                                AML (Age 10--19)     102                             Communitypoverty level NS                                        --                                           --                                                                  --
  Walters 1972[f](#nt118){ref-type="table-fn"}                                                 USA              Medianduration           ALL           334                                        --                                                    --               **16.2 months lowest SES** **vs. 24.3 months** **highest**                                      --

ALL -- acute lymphoblastic leukemia; AML -- acute myeloid leukemia; CNS -- central nervous system tumors; EFS -- event free survival; ES -- Ewing sarcoma; GCT -- germ cell tumors; HR -- hazard ratio; LR -- log rank; MB -- medulloblastoma; N -- number; NB -- neuroblastoma; NHL -- non-Hodgkin lymphoma; OR -- odds ratio; OS -- overall survival; OST -- osteosarcoma; RR -- relative risk; SES -- socioeconomic status; STS -- soft tissue sarcoma; UK -- United Kingdom; USA -- United States of America.

Bolded variables indicate statistically significant associations. Magnitudes of non-significant associations and confidence intervals of significant associations can be found in [Table S2](#pone.0089482.s003){ref-type="supplementary-material"}, along with definitions of each variable.

Education measures also include occupation-based measures.

Individual malignancies within the overall category showed no significant association between SES and outcome.

Adolescent and young adult population.

Immigrant patients from one center were compared to a historical control.

Within the overall malignancy category, leukemias did show a significant association between lower SES and inferior outcome.

No statistical analysis was presented, though the authors state that survival was "directly related to SES".

[Figure 3](#pone-0089482-g003){ref-type="fig"} illustrates each HIC association plotted by the study sample size. Of the 21 measures of association between ecologic SES variables and outcome, 15 (71.4%) showed lower SES to be associated with worse survival, five of which were statistically significant. The remaining six (28.6%) showed that lower SES was associated with superior outcome, none of which were statistically significant.

![Associations between socioeconomic measures and event-free and overall survival in high-income countries.\
A. Ecologic measures B. Measures of material possession, family composition, insurance status, immigrant status, and health care accessibility. C. Measures of education and occupation. D. Measures of income. Positive = lower socioeconomic status associated with inferior outcome; Negative = lower socioeconomic status associated with superior outcome. Magnitudes of association are not plotted. Statistically significance is denoted in red. Data points with a number above represent multiple socioeconomic variables. 3\* indicates 2 non-significant associations and one significant association.](pone.0089482.g003){#pone-0089482-g003}

Of the 15 measures of association between individual parental education and outcome, ten (66.7%) showed that lower parental education was associated with worse survival, three of which were statistically significant. None of the five (38.5%) associations in which higher parental education was associated with worse survival were statistically significant.

Two studies examined the impact of family income. In one study, there was no association between annual income categorized above and below \$30,000 and EFS (HR = 1.0). [@pone.0089482-Bhatia1] The second study found that lower income was associated with worse OS though the association was not statistically significant. [@pone.0089482-Syse1].

Of the 14 associations between the remaining individual-level SES variables and outcome, 12 (85.7%) showed that worse SES was associated with inferior outcome, seven of which were statistically significant. Two (14.3%) studies showed that better SES was associated with worse outcome. One of these two was statistically significant; among children with ALL in Greece, a higher number of siblings was associated with a lower risk of death (HR 0.63 per child; 95% CI 0.40--0.99). [@pone.0089482-Charalampopoulou1].

[Figure S1](#pone.0089482.s001){ref-type="supplementary-material"} illustrates all associations between SES measures (individual or ecologic) and outcome from the subset of HIC studies conducted in the United States. Of eleven associations, eight (72.7%) showed that lower SES was associated with worse outcome; two were statistically significant. There were three associations in which better SES was associated with worse survival; none were statistically significant.

Attributable Risk {#s3c}
-----------------

[Table 5](#pone-0089482-t005){ref-type="table"} shows the proportion of adverse outcomes attributable to low socioeconomic measures of income or insurance as calculated from LMIC and HIC studies. Based on the selected studies, and assuming both causality and the absence of significant bias or confounding, eliminating the adverse effect of low socioeconomic status would result in a theoretical 22.9% to 74.8% reduction in adverse outcome among LMIC children. Among HIC children, 0.0% to 31.9% of adverse outcomes could be avoided.

10.1371/journal.pone.0089482.t005

###### Proportion of adverse outcomes (attributable risk) due to poor socioeconomic prognosticators in studies of the effect of dichotomous measures of income and insurance in acute lymphoblastic leukemia and Hodgkin lymphoma, as well as of selected biologic prognosticators by way of comparison.
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                    Malignancy           Country            Category                 Adverse Prognosticator                 p~e~    RR     AR
  ---------------- ------------ -------------------------- ---------- ---------------------------------------------------- ------ ------ -------
  Dinand 2007           HL                India               LMIC     Low SES, based on aggregate score including income   0.67   5.4    74.8%
  Mostert 2010         ALL                Brazil              LMIC       Monthly per capita income \<0.4 ×minimum wage      0.25   1.2    22.9%
  Viana 1998           ALL              Indonesia             LMIC            2nd/3rd class ward, based on income           0.76   2.6    55.0%
  Tang 2008            ALL                China               LMIC                Rural residence/no insurance              0.74   1.8    37.1%
  Bhatia 2002          ALL             USA, Canada            HIC              Annual household income \<\$30,000           0.56   1.0    0.0%
  Hord 1996            ALL                 USA                HIC          At least partially uncovered by insurance        0.29   1.6    15.7%
  Lightfoot 2012       ALL       England, Scotland, Wales     HIC            Deprived area, based in part on income         0.39   1.3    10.2%
  Metzger 2008          HL                 USA                HIC            County with high % children in poverty         0.52   1.9    31.9%
  Borowitz 2008       SR-ALL             Multiple             HIC                          MRD\>0.01%                       0.14   7.2    45.6%
  Borowitz 2008       HR-ALL             Multiple             HIC                          MRD\>0.01%                       0.30   3.2    39.4%
  Loken 2012           AML               Multiple             HIC              Residual disease by flow cytometry           0.22   2.17   20.5%
  Chen 2012            ALL               Multiple             HIC                    High CRLF2 expression                  0.18   1.86   13.1%

ALL -- acute lymphoblastic leukemia; AML -- acute myeloid leukemia; AR -- attributable risk; HIC -- high-income country; HL -- Hodgkin lymphoma; LMIC -- low- to middle-income country; MRD -- minimal residual disease; p~e~ -- proportion of population exposed to the adverse prognosticator; RR -- risk ratio; SES -- socioeconomic status.

Discussion {#s4}
==========

In this systematic review, we found that among children with cancer in LMIC, measures of low SES were uniformly associated with inferior outcome. The majority of these associations were statistically significant. The results in HIC were less uniform although the majority of associations (including all but one of the statistically significant associations) also linked lower SES and worse outcome.

We chose to include multiple measures of SES in this systematic review, as SES indicators measure "different, often related aspects of socioeconomic stratification and may be more or less relevant to different health outcomes." [@pone.0089482-Galobardes1] This issue may be particularly pronounced in pediatric oncology, where mechanisms linking SES and outcome are likely complex and inter-related, as illustrated in [Figure 4](#pone-0089482-g004){ref-type="fig"}. These mechanisms have been suggested by previous authors as outlined in the figure legend, but are often theoretical with little empiric basis.

![Mechanisms linking socioeconomic status domains to both general and childhood cancer specific health outcomes.\
Domains and general mechanisms are adapted from the work of Galobardes et?al., Braveman et?al., Krieger et?al. and Marmot. Several childhood specific mechanisms are suggested by Bhatia et?al., Gage, Viana et?al. and Gupta et?al. These mechanisms are often theoretical with little empiric basis.](pone.0089482.g004){#pone-0089482-g004}

Based on this framework, our finding that all measures of low SES in LMIC were associated with inferior outcome implies that in these settings, many mechanisms link SES and outcome. Interventions targeting a particular mechanism in LMIC are therefore likely to decrease but not erase socioeconomic gradients in outcome. For example, while the provision of free treatment, accommodation and transport to families in El Salvador resulted in a decrease in abandonment rates to 13%, socioeconomic variables remained the strongest predictors of abandonment. [@pone.0089482-Bonilla2] Multi-faceted interventions are thus required in order to completely eliminate the negative influence of poor SES in LMIC.

Turning to studies conducted in HIC, income-based measures of SES were not significantly associated with outcome, though were infrequently investigated. By contrast, measures encompassing paternal education, material possession, and insurance status were often statistically associated with inferior outcome. This contrast to the LMIC findings has several potential explanations. First, a negative influence of low SES in HIC may be present but weaker than in LMIC, such that HIC studies were more likely to be underpowered. As the majority of non-significant associations were in the direction of low SES being associated with inferior outcome, this hypothesis is plausible.

Alternatively, only some of the pathways illustrated in [Figure 4](#pone-0089482-g004){ref-type="fig"} may be relevant in HIC. Interestingly, both American studies examining the effect of insurance coverage found the lack of full coverage to be significantly associated with inferior survival. [@pone.0089482-Kent1], [@pone.0089482-Hord1] In HIC, measures of access to health care may therefore be more relevant than, for example, measures of income. It is also likely that the impact of different aspects of SES will vary between settings and malignancies. For example, different measures of SES are likely to be relevant in countries with universal access to health care than in those without. Compliance will have a greater potential effect upon outcome in malignancies for which outpatient oral chemotherapy plays a major role than those involving mainly inpatient therapy.

Implications for Future Studies {#s4a}
-------------------------------

Future studies must move beyond choosing socioeconomic variables and outcomes based simply on what data are easily available to the investigators. Instead, authors should posit specific mechanisms and potential confounders in advance, identify measures of SES and outcomes consistent with the hypothesis, and only then examine for significant associations. For example, Bhatia et?al. measured rates of compliance to oral chemotherapy among American children with ALL. Low rates of compliance were linked to single mother households and associated with higher rates of relapse. [@pone.0089482-Bhatia2] Demonstrating the role of a particular pathway thus not only leads to a deeper understanding of the impact of SES, but also to plausible interventions mediating the pathway.

While such studies are likely to be complex, their impact may be significant. We have shown that improving the outcome of children of low SES to that of their high SES brethren would result in the elimination of up to 74.8% of adverse outcomes in LMIC and up to 31.9% of adverse outcomes in HIC. By way of comparison, minimal residual disease accounts for a theoretical 39.4% of relapse in high-risk ALL, while the novel feature of high CRLF2 expression accounts for 13.1% of relapse among all children with ALL. [@pone.0089482-Borowitz1], [@pone.0089482-Chen1] Consequently, debate on how low SES can be targeted is warranted, both in LMIC and HIC. Targeted interventions could encompass more frequent follow-up, intensive compliance monitoring, or other stratagems.

Strengths and Limitations {#s4b}
-------------------------

This study represents the first comprehensive assessment of the effect of SES on children with cancer. Other strengths include the lack of language-based restrictions and the exclusion of ethnicity, allowing for the role of biologic confounders to be minimized. Our main limitation was the inability to compare magnitudes of associations across studies. Even when multiple studies used both the same outcome (e.g. EFS) and exposure (e.g. income), different units of analysis were used (richest income quintile vs. poorest income quintile, per \$100 monthly income). In previous work we showed the effect of monthly income upon EFS in children with ALL in El Salvador was HR = 0.81 per \$100. [@pone.0089482-Gupta1] Comparing the richest quartile to the poorest in the identical population would have resulted in a HR of 0.45. Thus meaningful comparisons can only be made when the analysis unit is identical. This also rendered the use of Forest plots inappropriate. Our figures instead were restricted to illustrating effect direction and significance. In the future, individual-level meta-analyses may be useful in this regard as long as the non-categorized covariate (e.g. monthly income) was collected. Secondly, it is possible that publication bias is present, particularly in studies of LMIC. Finally, the incidence of ALL has itself been linked to high SES in some studies. [@pone.0089482-Stiller1] For this to explain the findings of our systematic review, the biologic driver behind this association would have to be specific to a low-risk form of ALL across multiple populations. While we cannot rule this possibility out, this would not explain the association between SES and outcome seen in other cancers.

In conclusion, low SES is uniformly associated with poorer outcomes among LMIC children with cancer, and widespread among HIC children. Future studies should identify specific mechanisms underlying these gradients, as well as evaluate interventions aimed at improving the outcome of children with cancer with socioeconomic risk factors.
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**Associations between socioeconomic measures and event-free and overall survival in studies conducted in the United States.** Positive = lower socioeconomic status associated with inferior outcome; Negative = lower socioeconomic status associated with superior outcome. Magnitudes of association are not plotted. Thus points distal from the y-axis may represent stronger, weaker or equivalent associations than proximal points.
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**Eligible studies examining the impact of socioeconomic status upon outcome in children with cancer in low- and middle-income countries.** ALL -- acute lymphoblastic leukemia; AML -- acute myeloid leukemia; DFS -- disease free survival; EFS -- event free survival; HR -- hazard ratio; N -- number; OS -- overall survival; SES -- socioeconomic status; TRM -- treatment related mortality. Bolded variables indicate statistically significant associations. ^a^The marginalization index used by Carlos et?al. is an ecologic measure of SES; all other variables in the table are measures of individual-level SES.
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**Eligible studies examining the impact of socioeconomic status upon outcome in children with cancer in high-income countries.** ALL -- acute lymphoblastic leukemia; AML -- acute myeloid leukemia; CNS -- central nervous system tumors; EFS -- event free survival; ES -- Ewing sarcoma; GCT -- germ cell tumors; HR -- hazard ratio; MB -- medulloblastoma; N -- number; NB -- neuroblastoma; NHL -- non-Hodgkin lymphoma; OR -- odds ratio; OS -- overall survival; OST -- osteosarcoma; RR -- relative risk; SES -- socioeconomic status; STS -- soft tissue sarcoma; UK -- United Kingdom; USA -- United States of America. Bolded variables indicate statistically significant associations. ^a^Individual malignancies within the overall category showed no significant association between SES and outcome. ^b^Adolescent and young adult population. ^c^Within the overall malignancy category, leukemias did show a significant association between lower SES and inferior outcome. ^d^Immigrant patients from one center were compared to a historical control. ^e^No statistical analysis was presented, though the authors state that survival was "directly related to SES". ^f^HR is per level of occupation.
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